CXCL12 and coronary artery disorder: Recently, administration of Cxcl12 to injured hearts, a chemokine that binds the receptor Cxcr4 and is key for EC chemotactic migration, has shown a significant effect on the development of collateral arteries in ischemic heart disease [309].